初次全关节置换术后并非所有患者都需要常规基础代谢组合检查:降低费用的机会
该研究回顾了2018年1月1日至12月31日在一家三级医疗中心进行的802例(758名患者)初次下肢全关节置换术病例,评估术后异常基础代谢组合(BMP)导致干预的 prevalence 并识别术后需要BMP的预测因素。结果显示1032次术后BMP中958次(93%)未引发干预,相当于34,488美元可避免的BMP费用;27例(3.4%)因异常BMP需要干预,独立预测因素包括术前肾功能不全(OR 7.8,95%CI 2.8-22)、当前肾毒性药物数量(OR 1.9,95%CI 1.3-2.9)和年龄校正Charlson合并症指数(OR 1.2,95%CI 1.0-1.5)。结论认为对大多数初次全关节置换术患者,常规术后BMP是不必要的,检测可保留给肾功能不全、服用多种肾毒性药物或AA-CCI值高的患者。
要点
- 术后1032次BMP中958次(93%)未引发干预,相当于34,488美元可避免费用。
- 仅27例(3.4%)因异常BMP需要干预,独立预测因素为术前肾功能不全、肾毒性药物数量和AA-CCI。
- 作者认为常规术后BMP对大多数初次TJA患者不必要,检测可保留给高风险患者。
核心结论
- 对大多数初次全关节置换术患者,常规术后BMP是不必要的;检测可保留给肾功能不全、服用多种肾毒性药物或AA-CCI值高的患者。
研究设计与样本
- 回顾性审查2018年1月1日至12月31日在一家三级医疗中心进行的802例(758名患者)初次下肢全关节置换术病例。
主要发现
- 共开具1032次术后BMP,其中958次(93%)未引发干预,相当于34,488美元可避免的BMP费用。
- 27例(3.4%)因异常BMP需要干预。
- 干预的独立预测因素包括术前肾功能不全(即肌酐异常或肾小球滤过率<60 mL/min)(OR 7.8;95%CI 2.8-22)、当前肾毒性药物数量(OR 1.9;95%CI 1.3-2.9)和AA-CCI值(OR 1.2;95%CI 1.0-1.5)。
关键数值与推荐
- 本机构BMP成本为36美元。
- 术前肾功能不全(即肌酐异常或肾小球滤过率<60 mL/min)的OR为7.8(95%CI 2.8-22)。
- 当前肾毒性药物数量的OR为1.9(95%CI 1.3-2.9)。
- AA-CCI值的OR为1.2(95%CI 1.0-1.5)。
临床怎么用
- 作者认为常规术后BMP对大多数初次TJA患者不必要,检测可保留给肾功能不全、服用多种肾毒性药物或AA-CCI值高的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the incidence of total joint arthroplasty (TJA) increases, identifying methods for cost reduction is essential. Basic metabolic panels (BMPs) are obtained routinely after TJA. We aimed at assessing the prevalence of intervention secondary to abnormal BMPs after primary TJA and at identifying predictors of the need for postoperative BMPs. METHODS: We reviewed 802 cases (758 patients) of primary lower-extremity TJA performed from January 1 through December 31, 2018, at our tertiary care medical center. Patient characteristics, preoperative and postoperative BMPs, comorbidities, current medications, and in-hospital interventions were recorded. Age-adjusted Charlson Comorbidity Index (AA-CCI) values were calculated. Institutional costs of 1 BMP and of all BMPs not prompting intervention were calculated. We used multiple regression to identify independent predictors of in-hospital interventions secondary to abnormal postoperative BMPs. RESULTS: Our institutional BMP cost was $36. A total of 1032 postoperative BMPs were ordered; 958 (93%) prompted no intervention. This equated to $34,488 of avoidable BMP costs. We identified 27 cases (3.4%) requiring intervention secondary to abnormal BMPs. Independent predictors of intervention were preoperative renal dysfunction (ie, abnormal creatinine or glomerular filtration rate <60 mL/min) (odds ratio [OR], 7.8; 95% confidence interval [CI], 2.8-22), number of current nephrotoxic medications (OR, 1.9; 95% CI, 1.3-2.9), and AA-CCI value (OR, 1.2; 95% CI, 1.0-1.5). CONCLUSION: Routine postoperative BMPs are unwarranted for most patients undergoing primary TJA. Testing may be reserved for those with renal dysfunction, those taking multiple nephrotoxic medications, or those with a high AA-CCI value.
引用
- Chaudhry YP, Rao SS, Hasan SA, et al. Routine Basic Metabolic Panels Are Not Needed in All Patients After Primary Total Joint Arthroplasty: An Opportunity for Cost Reduction. J Arthroplasty. 2020. PMID: 32994110. doi:10.1016/j.arth.2020.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。